The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2193-6382

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660 ; volume:12 ; number:1 ; day:7 ; month:11 ; year:2022 ; pages:1-7 ; date:1.2023
Infectious diseases and therapy ; 12, Heft 1 (7.11.2022), 1-7, 1.2023

Creator: Orenstein, Robert

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40121-022-00714-9

URN: urn:nbn:de:101:1-2023033021043738432407

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Orenstein, Robert
SpringerLink (Online service)

Other Objects (12)

Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile

Mining the microbiome to modulate host defense against clostridioides difficile infections

Patient Education: Clostridioides difficile Infection

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Impact of ribotype on Clostridioides difficile diagnostics

Clostridioides Difficile Infection Presenting with Fulminant Colitis

Evidence-Based Commentary: Testing for Clostridioides difficile Infection

Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile

Mining the microbiome to modulate host defense against clostridioides difficile infections

Patient Education: Clostridioides difficile Infection

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Impact of ribotype on Clostridioides difficile diagnostics

Clostridioides Difficile Infection Presenting with Fulminant Colitis

Evidence-Based Commentary: Testing for Clostridioides difficile Infection

Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile

Mining the microbiome to modulate host defense against clostridioides difficile infections

Patient Education: Clostridioides difficile Infection

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Impact of ribotype on Clostridioides difficile diagnostics

Clostridioides Difficile Infection Presenting with Fulminant Colitis

Evidence-Based Commentary: Testing for Clostridioides difficile Infection

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile

Mining the microbiome to modulate host defense against clostridioides difficile infections

Patient Education: Clostridioides difficile Infection

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Impact of ribotype on Clostridioides difficile diagnostics

Clostridioides Difficile Infection Presenting with Fulminant Colitis

Evidence-Based Commentary: Testing for Clostridioides difficile Infection

Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile

Mining the microbiome to modulate host defense against clostridioides difficile infections

Patient Education: Clostridioides difficile Infection

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Impact of ribotype on Clostridioides difficile diagnostics

Clostridioides Difficile Infection Presenting with Fulminant Colitis

Evidence-Based Commentary: Testing for Clostridioides difficile Infection

Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile

Mining the microbiome to modulate host defense against clostridioides difficile infections

Patient Education: Clostridioides difficile Infection

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Editorial: Rejuvenating the Microbiome in Recurrent Clostridioides difficile Infection with Fecal Microbiota Transplant

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

Globale genomische Epidemiologie von Clostridioides difficile

Gut metabolites predict Clostridioides difficile recurrence

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Impact of ribotype on Clostridioides difficile diagnostics

Clostridioides Difficile Infection Presenting with Fulminant Colitis

Evidence-Based Commentary: Testing for Clostridioides difficile Infection

Related objects

Reset password